List of SBIR/STTR awards granted to Vitan-Biotech LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Vitan-Biotech LLC in April, 2020 for $224,940.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DA051296-01 | Phase I | 224,940 | April 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Vitan-Biotech LLC in August, 2019 for $149,938.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM133219-01A1 | Phase I | 149,938 | August 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Vitan-Biotech LLC in August, 2020 for $222,939.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM139437-01 | Phase I | 222,939 | August 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Vitan-Biotech LLC in March, 2017 for $131,697.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DA042664-01 | Phase I | 131,697 | March 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Vitan-Biotech LLC for $149,996.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2002016M89702 | Phase I | 149,996 | ||||||||
A SBIR Phase I contract was awarded to Vitan-Biotech LLC for $249,946.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201700027C-0-0-0 | Phase I | 249,946 | ||||||||
A SBIR Phase I contract was awarded to Vitan-Biotech LLC for $149,991.0 USD from the U.S. Department of Health & Human Services. | SBIR | 200-2015-M-88085 | Phase I | 149,991 | ||||||||
A SBIR Phase I contract was awarded to Vitan-Biotech LLC in September, 2023 for $218,622.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM149069-01 | Phase I | 218,622 | September 22, 2023 |
